Global mRNA Vaccines for Animals Market Growth 2025-2031

July 2025 | 116 pages | ID: M9181EF89603EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global mRNA Vaccines for Animals market size is predicted to grow from US$ 21.7 million in 2025 to US$ 39.5 million in 2031; it is expected to grow at a CAGR of 10.5% from 2025 to 2031.

mRNA vaccines for animals are a type of veterinary vaccine that use messenger RNA (mRNA) technology to stimulate an immune response against specific pathogens in livestock, pets, and other animals. These vaccines work by delivering synthetic mRNA encoding viral or bacterial antigens into the animal’s cells, prompting the immune system to recognize and fight the targeted disease. Compared to traditional vaccines, mRNA vaccines offer faster development timelines, improved efficacy, and the ability to rapidly adapt to emerging animal diseases. They are being explored for various applications, including livestock diseases (such as foot-and-mouth disease), zoonotic infections, and companion animal health.

United States market for mRNA Vaccines for Animals is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for mRNA Vaccines for Animals is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for mRNA Vaccines for Animals is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key mRNA Vaccines for Animals players cover Ceva Animal Health, Merck Animal Health, Areterna, Bayer, BioNTech, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “mRNA Vaccines for Animals Industry Forecast” looks at past sales and reviews total world mRNA Vaccines for Animals sales in 2024, providing a comprehensive analysis by region and market sector of projected mRNA Vaccines for Animals sales for 2025 through 2031. With mRNA Vaccines for Animals sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world mRNA Vaccines for Animals industry.

This Insight Report provides a comprehensive analysis of the global mRNA Vaccines for Animals landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on mRNA Vaccines for Animals portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global mRNA Vaccines for Animals market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for mRNA Vaccines for Animals and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global mRNA Vaccines for Animals.

This report presents a comprehensive overview, market shares, and growth opportunities of mRNA Vaccines for Animals market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
  • Injectable Drug Administration
  • Non-invasive Drug Administration
Segmentation by Application:
  • for Poultry
  • for Livestock
  • Others
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
  • Ceva Animal Health
  • Merck Animal Health
  • Areterna
  • Bayer
  • BioNTech
  • Genvax Technologies
  • BioVenic
  • Moderna
  • Ruipu Biotechnology
  • Jinyu Bio-technology
  • Shanghai Shen Lian Biomedical
  • Suzhou Kerui Meide Biomedical Technology
  • Shanghai Rnacure Biopharma
Key Questions Addressed in this Report

What is the 10-year outlook for the global mRNA Vaccines for Animals market?
What factors are driving mRNA Vaccines for Animals market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do mRNA Vaccines for Animals market opportunities vary by end market size?
How does mRNA Vaccines for Animals break out by Type, by Application?
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global mRNA Vaccines for Animals Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for mRNA Vaccines for Animals by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for mRNA Vaccines for Animals by Country/Region, 2020, 2024 & 2031
2.2 mRNA Vaccines for Animals Segment by Type
  2.2.1 Injectable Drug Administration
  2.2.2 Non-invasive Drug Administration
2.3 mRNA Vaccines for Animals Sales by Type
  2.3.1 Global mRNA Vaccines for Animals Sales Market Share by Type (2020-2025)
  2.3.2 Global mRNA Vaccines for Animals Revenue and Market Share by Type (2020-2025)
  2.3.3 Global mRNA Vaccines for Animals Sale Price by Type (2020-2025)
2.4 mRNA Vaccines for Animals Segment by Application
  2.4.1 for Poultry
  2.4.2 for Livestock
  2.4.3 Others
2.5 mRNA Vaccines for Animals Sales by Application
  2.5.1 Global mRNA Vaccines for Animals Sale Market Share by Application (2020-2025)
  2.5.2 Global mRNA Vaccines for Animals Revenue and Market Share by Application (2020-2025)
  2.5.3 Global mRNA Vaccines for Animals Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global mRNA Vaccines for Animals Breakdown Data by Company
  3.1.1 Global mRNA Vaccines for Animals Annual Sales by Company (2020-2025)
  3.1.2 Global mRNA Vaccines for Animals Sales Market Share by Company (2020-2025)
3.2 Global mRNA Vaccines for Animals Annual Revenue by Company (2020-2025)
  3.2.1 Global mRNA Vaccines for Animals Revenue by Company (2020-2025)
  3.2.2 Global mRNA Vaccines for Animals Revenue Market Share by Company (2020-2025)
3.3 Global mRNA Vaccines for Animals Sale Price by Company
3.4 Key Manufacturers mRNA Vaccines for Animals Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers mRNA Vaccines for Animals Product Location Distribution
  3.4.2 Players mRNA Vaccines for Animals Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR MRNA VACCINES FOR ANIMALS BY GEOGRAPHIC REGION

4.1 World Historic mRNA Vaccines for Animals Market Size by Geographic Region (2020-2025)
  4.1.1 Global mRNA Vaccines for Animals Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global mRNA Vaccines for Animals Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic mRNA Vaccines for Animals Market Size by Country/Region (2020-2025)
  4.2.1 Global mRNA Vaccines for Animals Annual Sales by Country/Region (2020-2025)
  4.2.2 Global mRNA Vaccines for Animals Annual Revenue by Country/Region (2020-2025)
4.3 Americas mRNA Vaccines for Animals Sales Growth
4.4 APAC mRNA Vaccines for Animals Sales Growth
4.5 Europe mRNA Vaccines for Animals Sales Growth
4.6 Middle East & Africa mRNA Vaccines for Animals Sales Growth

5 AMERICAS

5.1 Americas mRNA Vaccines for Animals Sales by Country
  5.1.1 Americas mRNA Vaccines for Animals Sales by Country (2020-2025)
  5.1.2 Americas mRNA Vaccines for Animals Revenue by Country (2020-2025)
5.2 Americas mRNA Vaccines for Animals Sales by Type (2020-2025)
5.3 Americas mRNA Vaccines for Animals Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC mRNA Vaccines for Animals Sales by Region
  6.1.1 APAC mRNA Vaccines for Animals Sales by Region (2020-2025)
  6.1.2 APAC mRNA Vaccines for Animals Revenue by Region (2020-2025)
6.2 APAC mRNA Vaccines for Animals Sales by Type (2020-2025)
6.3 APAC mRNA Vaccines for Animals Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe mRNA Vaccines for Animals by Country
  7.1.1 Europe mRNA Vaccines for Animals Sales by Country (2020-2025)
  7.1.2 Europe mRNA Vaccines for Animals Revenue by Country (2020-2025)
7.2 Europe mRNA Vaccines for Animals Sales by Type (2020-2025)
7.3 Europe mRNA Vaccines for Animals Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa mRNA Vaccines for Animals by Country
  8.1.1 Middle East & Africa mRNA Vaccines for Animals Sales by Country (2020-2025)
  8.1.2 Middle East & Africa mRNA Vaccines for Animals Revenue by Country (2020-2025)
8.2 Middle East & Africa mRNA Vaccines for Animals Sales by Type (2020-2025)
8.3 Middle East & Africa mRNA Vaccines for Animals Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of mRNA Vaccines for Animals
10.3 Manufacturing Process Analysis of mRNA Vaccines for Animals
10.4 Industry Chain Structure of mRNA Vaccines for Animals

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 mRNA Vaccines for Animals Distributors
11.3 mRNA Vaccines for Animals Customer

12 WORLD FORECAST REVIEW FOR MRNA VACCINES FOR ANIMALS BY GEOGRAPHIC REGION

12.1 Global mRNA Vaccines for Animals Market Size Forecast by Region
  12.1.1 Global mRNA Vaccines for Animals Forecast by Region (2026-2031)
  12.1.2 Global mRNA Vaccines for Animals Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global mRNA Vaccines for Animals Forecast by Type (2026-2031)
12.7 Global mRNA Vaccines for Animals Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Ceva Animal Health
  13.1.1 Ceva Animal Health Company Information
  13.1.2 Ceva Animal Health mRNA Vaccines for Animals Product Portfolios and Specifications
  13.1.3 Ceva Animal Health mRNA Vaccines for Animals Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Ceva Animal Health Main Business Overview
  13.1.5 Ceva Animal Health Latest Developments
13.2 Merck Animal Health
  13.2.1 Merck Animal Health Company Information
  13.2.2 Merck Animal Health mRNA Vaccines for Animals Product Portfolios and Specifications
  13.2.3 Merck Animal Health mRNA Vaccines for Animals Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Merck Animal Health Main Business Overview
  13.2.5 Merck Animal Health Latest Developments
13.3 Areterna
  13.3.1 Areterna Company Information
  13.3.2 Areterna mRNA Vaccines for Animals Product Portfolios and Specifications
  13.3.3 Areterna mRNA Vaccines for Animals Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 Areterna Main Business Overview
  13.3.5 Areterna Latest Developments
13.4 Bayer
  13.4.1 Bayer Company Information
  13.4.2 Bayer mRNA Vaccines for Animals Product Portfolios and Specifications
  13.4.3 Bayer mRNA Vaccines for Animals Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 Bayer Main Business Overview
  13.4.5 Bayer Latest Developments
13.5 BioNTech
  13.5.1 BioNTech Company Information
  13.5.2 BioNTech mRNA Vaccines for Animals Product Portfolios and Specifications
  13.5.3 BioNTech mRNA Vaccines for Animals Sales, Revenue, Price and Gross Margin (2020-2025)
  13.5.4 BioNTech Main Business Overview
  13.5.5 BioNTech Latest Developments
13.6 Genvax Technologies
  13.6.1 Genvax Technologies Company Information
  13.6.2 Genvax Technologies mRNA Vaccines for Animals Product Portfolios and Specifications
  13.6.3 Genvax Technologies mRNA Vaccines for Animals Sales, Revenue, Price and Gross Margin (2020-2025)
  13.6.4 Genvax Technologies Main Business Overview
  13.6.5 Genvax Technologies Latest Developments
13.7 BioVenic
  13.7.1 BioVenic Company Information
  13.7.2 BioVenic mRNA Vaccines for Animals Product Portfolios and Specifications
  13.7.3 BioVenic mRNA Vaccines for Animals Sales, Revenue, Price and Gross Margin (2020-2025)
  13.7.4 BioVenic Main Business Overview
  13.7.5 BioVenic Latest Developments
13.8 Moderna
  13.8.1 Moderna Company Information
  13.8.2 Moderna mRNA Vaccines for Animals Product Portfolios and Specifications
  13.8.3 Moderna mRNA Vaccines for Animals Sales, Revenue, Price and Gross Margin (2020-2025)
  13.8.4 Moderna Main Business Overview
  13.8.5 Moderna Latest Developments
13.9 Ruipu Biotechnology
  13.9.1 Ruipu Biotechnology Company Information
  13.9.2 Ruipu Biotechnology mRNA Vaccines for Animals Product Portfolios and Specifications
  13.9.3 Ruipu Biotechnology mRNA Vaccines for Animals Sales, Revenue, Price and Gross Margin (2020-2025)
  13.9.4 Ruipu Biotechnology Main Business Overview
  13.9.5 Ruipu Biotechnology Latest Developments
13.10 Jinyu Bio-technology
  13.10.1 Jinyu Bio-technology Company Information
  13.10.2 Jinyu Bio-technology mRNA Vaccines for Animals Product Portfolios and Specifications
  13.10.3 Jinyu Bio-technology mRNA Vaccines for Animals Sales, Revenue, Price and Gross Margin (2020-2025)
  13.10.4 Jinyu Bio-technology Main Business Overview
  13.10.5 Jinyu Bio-technology Latest Developments
13.11 Shanghai Shen Lian Biomedical
  13.11.1 Shanghai Shen Lian Biomedical Company Information
  13.11.2 Shanghai Shen Lian Biomedical mRNA Vaccines for Animals Product Portfolios and Specifications
  13.11.3 Shanghai Shen Lian Biomedical mRNA Vaccines for Animals Sales, Revenue, Price and Gross Margin (2020-2025)
  13.11.4 Shanghai Shen Lian Biomedical Main Business Overview
  13.11.5 Shanghai Shen Lian Biomedical Latest Developments
13.12 Suzhou Kerui Meide Biomedical Technology
  13.12.1 Suzhou Kerui Meide Biomedical Technology Company Information
  13.12.2 Suzhou Kerui Meide Biomedical Technology mRNA Vaccines for Animals Product Portfolios and Specifications
  13.12.3 Suzhou Kerui Meide Biomedical Technology mRNA Vaccines for Animals Sales, Revenue, Price and Gross Margin (2020-2025)
  13.12.4 Suzhou Kerui Meide Biomedical Technology Main Business Overview
  13.12.5 Suzhou Kerui Meide Biomedical Technology Latest Developments
13.13 Shanghai Rnacure Biopharma
  13.13.1 Shanghai Rnacure Biopharma Company Information
  13.13.2 Shanghai Rnacure Biopharma mRNA Vaccines for Animals Product Portfolios and Specifications
  13.13.3 Shanghai Rnacure Biopharma mRNA Vaccines for Animals Sales, Revenue, Price and Gross Margin (2020-2025)
  13.13.4 Shanghai Rnacure Biopharma Main Business Overview
  13.13.5 Shanghai Rnacure Biopharma Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

LIST OF TABLES

Table 1. mRNA Vaccines for Animals Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. mRNA Vaccines for Animals Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Injectable Drug Administration
Table 4. Major Players of Non-invasive Drug Administration
Table 5. Global mRNA Vaccines for Animals Sales by Type (2020-2025) & (K Dose)
Table 6. Global mRNA Vaccines for Animals Sales Market Share by Type (2020-2025)
Table 7. Global mRNA Vaccines for Animals Revenue by Type (2020-2025) & ($ million)
Table 8. Global mRNA Vaccines for Animals Revenue Market Share by Type (2020-2025)
Table 9. Global mRNA Vaccines for Animals Sale Price by Type (2020-2025) & (US$/Dose)
Table 10. Global mRNA Vaccines for Animals Sale by Application (2020-2025) & (K Dose)
Table 11. Global mRNA Vaccines for Animals Sale Market Share by Application (2020-2025)
Table 12. Global mRNA Vaccines for Animals Revenue by Application (2020-2025) & ($ million)
Table 13. Global mRNA Vaccines for Animals Revenue Market Share by Application (2020-2025)
Table 14. Global mRNA Vaccines for Animals Sale Price by Application (2020-2025) & (US$/Dose)
Table 15. Global mRNA Vaccines for Animals Sales by Company (2020-2025) & (K Dose)
Table 16. Global mRNA Vaccines for Animals Sales Market Share by Company (2020-2025)
Table 17. Global mRNA Vaccines for Animals Revenue by Company (2020-2025) & ($ millions)
Table 18. Global mRNA Vaccines for Animals Revenue Market Share by Company (2020-2025)
Table 19. Global mRNA Vaccines for Animals Sale Price by Company (2020-2025) & (US$/Dose)
Table 20. Key Manufacturers mRNA Vaccines for Animals Producing Area Distribution and Sales Area
Table 21. Players mRNA Vaccines for Animals Products Offered
Table 22. mRNA Vaccines for Animals Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global mRNA Vaccines for Animals Sales by Geographic Region (2020-2025) & (K Dose)
Table 26. Global mRNA Vaccines for Animals Sales Market Share Geographic Region (2020-2025)
Table 27. Global mRNA Vaccines for Animals Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global mRNA Vaccines for Animals Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global mRNA Vaccines for Animals Sales by Country/Region (2020-2025) & (K Dose)
Table 30. Global mRNA Vaccines for Animals Sales Market Share by Country/Region (2020-2025)
Table 31. Global mRNA Vaccines for Animals Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global mRNA Vaccines for Animals Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas mRNA Vaccines for Animals Sales by Country (2020-2025) & (K Dose)
Table 34. Americas mRNA Vaccines for Animals Sales Market Share by Country (2020-2025)
Table 35. Americas mRNA Vaccines for Animals Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas mRNA Vaccines for Animals Sales by Type (2020-2025) & (K Dose)
Table 37. Americas mRNA Vaccines for Animals Sales by Application (2020-2025) & (K Dose)
Table 38. APAC mRNA Vaccines for Animals Sales by Region (2020-2025) & (K Dose)
Table 39. APAC mRNA Vaccines for Animals Sales Market Share by Region (2020-2025)
Table 40. APAC mRNA Vaccines for Animals Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC mRNA Vaccines for Animals Sales by Type (2020-2025) & (K Dose)
Table 42. APAC mRNA Vaccines for Animals Sales by Application (2020-2025) & (K Dose)
Table 43. Europe mRNA Vaccines for Animals Sales by Country (2020-2025) & (K Dose)
Table 44. Europe mRNA Vaccines for Animals Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe mRNA Vaccines for Animals Sales by Type (2020-2025) & (K Dose)
Table 46. Europe mRNA Vaccines for Animals Sales by Application (2020-2025) & (K Dose)
Table 47. Middle East & Africa mRNA Vaccines for Animals Sales by Country (2020-2025) & (K Dose)
Table 48. Middle East & Africa mRNA Vaccines for Animals Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa mRNA Vaccines for Animals Sales by Type (2020-2025) & (K Dose)
Table 50. Middle East & Africa mRNA Vaccines for Animals Sales by Application (2020-2025) & (K Dose)
Table 51. Key Market Drivers & Growth Opportunities of mRNA Vaccines for Animals
Table 52. Key Market Challenges & Risks of mRNA Vaccines for Animals
Table 53. Key Industry Trends of mRNA Vaccines for Animals
Table 54. mRNA Vaccines for Animals Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. mRNA Vaccines for Animals Distributors List
Table 57. mRNA Vaccines for Animals Customer List
Table 58. Global mRNA Vaccines for Animals Sales Forecast by Region (2026-2031) & (K Dose)
Table 59. Global mRNA Vaccines for Animals Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas mRNA Vaccines for Animals Sales Forecast by Country (2026-2031) & (K Dose)
Table 61. Americas mRNA Vaccines for Animals Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC mRNA Vaccines for Animals Sales Forecast by Region (2026-2031) & (K Dose)
Table 63. APAC mRNA Vaccines for Animals Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe mRNA Vaccines for Animals Sales Forecast by Country (2026-2031) & (K Dose)
Table 65. Europe mRNA Vaccines for Animals Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa mRNA Vaccines for Animals Sales Forecast by Country (2026-2031) & (K Dose)
Table 67. Middle East & Africa mRNA Vaccines for Animals Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global mRNA Vaccines for Animals Sales Forecast by Type (2026-2031) & (K Dose)
Table 69. Global mRNA Vaccines for Animals Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global mRNA Vaccines for Animals Sales Forecast by Application (2026-2031) & (K Dose)
Table 71. Global mRNA Vaccines for Animals Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Ceva Animal Health Basic Information, mRNA Vaccines for Animals Manufacturing Base, Sales Area and Its Competitors
Table 73. Ceva Animal Health mRNA Vaccines for Animals Product Portfolios and Specifications
Table 74. Ceva Animal Health mRNA Vaccines for Animals Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 75. Ceva Animal Health Main Business
Table 76. Ceva Animal Health Latest Developments
Table 77. Merck Animal Health Basic Information, mRNA Vaccines for Animals Manufacturing Base, Sales Area and Its Competitors
Table 78. Merck Animal Health mRNA Vaccines for Animals Product Portfolios and Specifications
Table 79. Merck Animal Health mRNA Vaccines for Animals Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 80. Merck Animal Health Main Business
Table 81. Merck Animal Health Latest Developments
Table 82. Areterna Basic Information, mRNA Vaccines for Animals Manufacturing Base, Sales Area and Its Competitors
Table 83. Areterna mRNA Vaccines for Animals Product Portfolios and Specifications
Table 84. Areterna mRNA Vaccines for Animals Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 85. Areterna Main Business
Table 86. Areterna Latest Developments
Table 87. Bayer Basic Information, mRNA Vaccines for Animals Manufacturing Base, Sales Area and Its Competitors
Table 88. Bayer mRNA Vaccines for Animals Product Portfolios and Specifications
Table 89. Bayer mRNA Vaccines for Animals Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 90. Bayer Main Business
Table 91. Bayer Latest Developments
Table 92. BioNTech Basic Information, mRNA Vaccines for Animals Manufacturing Base, Sales Area and Its Competitors
Table 93. BioNTech mRNA Vaccines for Animals Product Portfolios and Specifications
Table 94. BioNTech mRNA Vaccines for Animals Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 95. BioNTech Main Business
Table 96. BioNTech Latest Developments
Table 97. Genvax Technologies Basic Information, mRNA Vaccines for Animals Manufacturing Base, Sales Area and Its Competitors
Table 98. Genvax Technologies mRNA Vaccines for Animals Product Portfolios and Specifications
Table 99. Genvax Technologies mRNA Vaccines for Animals Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 100. Genvax Technologies Main Business
Table 101. Genvax Technologies Latest Developments
Table 102. BioVenic Basic Information, mRNA Vaccines for Animals Manufacturing Base, Sales Area and Its Competitors
Table 103. BioVenic mRNA Vaccines for Animals Product Portfolios and Specifications
Table 104. BioVenic mRNA Vaccines for Animals Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 105. BioVenic Main Business
Table 106. BioVenic Latest Developments
Table 107. Moderna Basic Information, mRNA Vaccines for Animals Manufacturing Base, Sales Area and Its Competitors
Table 108. Moderna mRNA Vaccines for Animals Product Portfolios and Specifications
Table 109. Moderna mRNA Vaccines for Animals Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 110. Moderna Main Business
Table 111. Moderna Latest Developments
Table 112. Ruipu Biotechnology Basic Information, mRNA Vaccines for Animals Manufacturing Base, Sales Area and Its Competitors
Table 113. Ruipu Biotechnology mRNA Vaccines for Animals Product Portfolios and Specifications
Table 114. Ruipu Biotechnology mRNA Vaccines for Animals Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 115. Ruipu Biotechnology Main Business
Table 116. Ruipu Biotechnology Latest Developments
Table 117. Jinyu Bio-technology Basic Information, mRNA Vaccines for Animals Manufacturing Base, Sales Area and Its Competitors
Table 118. Jinyu Bio-technology mRNA Vaccines for Animals Product Portfolios and Specifications
Table 119. Jinyu Bio-technology mRNA Vaccines for Animals Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 120. Jinyu Bio-technology Main Business
Table 121. Jinyu Bio-technology Latest Developments
Table 122. Shanghai Shen Lian Biomedical Basic Information, mRNA Vaccines for Animals Manufacturing Base, Sales Area and Its Competitors
Table 123. Shanghai Shen Lian Biomedical mRNA Vaccines for Animals Product Portfolios and Specifications
Table 124. Shanghai Shen Lian Biomedical mRNA Vaccines for Animals Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 125. Shanghai Shen Lian Biomedical Main Business
Table 126. Shanghai Shen Lian Biomedical Latest Developments
Table 127. Suzhou Kerui Meide Biomedical Technology Basic Information, mRNA Vaccines for Animals Manufacturing Base, Sales Area and Its Competitors
Table 128. Suzhou Kerui Meide Biomedical Technology mRNA Vaccines for Animals Product Portfolios and Specifications
Table 129. Suzhou Kerui Meide Biomedical Technology mRNA Vaccines for Animals Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 130. Suzhou Kerui Meide Biomedical Technology Main Business
Table 131. Suzhou Kerui Meide Biomedical Technology Latest Developments
Table 132. Shanghai Rnacure Biopharma Basic Information, mRNA Vaccines for Animals Manufacturing Base, Sales Area and Its Competitors
Table 133. Shanghai Rnacure Biopharma mRNA Vaccines for Animals Product Portfolios and Specifications
Table 134. Shanghai Rnacure Biopharma mRNA Vaccines for Animals Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 135. Shanghai Rnacure Biopharma Main Business
Table 136. Shanghai Rnacure Biopharma Latest Developments

LIST OF FIGURES

Figure 1. Picture of mRNA Vaccines for Animals
Figure 2. mRNA Vaccines for Animals Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global mRNA Vaccines for Animals Sales Growth Rate 2020-2031 (K Dose)
Figure 7. Global mRNA Vaccines for Animals Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. mRNA Vaccines for Animals Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. mRNA Vaccines for Animals Sales Market Share by Country/Region (2024)
Figure 10. mRNA Vaccines for Animals Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Injectable Drug Administration
Figure 12. Product Picture of Non-invasive Drug Administration
Figure 13. Global mRNA Vaccines for Animals Sales Market Share by Type in 2025
Figure 14. Global mRNA Vaccines for Animals Revenue Market Share by Type (2020-2025)
Figure 15. mRNA Vaccines for Animals Consumed in for Poultry
Figure 16. Global mRNA Vaccines for Animals Market: for Poultry (2020-2025) & (K Dose)
Figure 17. mRNA Vaccines for Animals Consumed in for Livestock
Figure 18. Global mRNA Vaccines for Animals Market: for Livestock (2020-2025) & (K Dose)
Figure 19. mRNA Vaccines for Animals Consumed in Others
Figure 20. Global mRNA Vaccines for Animals Market: Others (2020-2025) & (K Dose)
Figure 21. Global mRNA Vaccines for Animals Sale Market Share by Application (2024)
Figure 22. Global mRNA Vaccines for Animals Revenue Market Share by Application in 2025
Figure 23. mRNA Vaccines for Animals Sales by Company in 2025 (K Dose)
Figure 24. Global mRNA Vaccines for Animals Sales Market Share by Company in 2025
Figure 25. mRNA Vaccines for Animals Revenue by Company in 2025 ($ millions)
Figure 26. Global mRNA Vaccines for Animals Revenue Market Share by Company in 2025
Figure 27. Global mRNA Vaccines for Animals Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global mRNA Vaccines for Animals Revenue Market Share by Geographic Region in 2025
Figure 29. Americas mRNA Vaccines for Animals Sales 2020-2025 (K Dose)
Figure 30. Americas mRNA Vaccines for Animals Revenue 2020-2025 ($ millions)
Figure 31. APAC mRNA Vaccines for Animals Sales 2020-2025 (K Dose)
Figure 32. APAC mRNA Vaccines for Animals Revenue 2020-2025 ($ millions)
Figure 33. Europe mRNA Vaccines for Animals Sales 2020-2025 (K Dose)
Figure 34. Europe mRNA Vaccines for Animals Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa mRNA Vaccines for Animals Sales 2020-2025 (K Dose)
Figure 36. Middle East & Africa mRNA Vaccines for Animals Revenue 2020-2025 ($ millions)
Figure 37. Americas mRNA Vaccines for Animals Sales Market Share by Country in 2025
Figure 38. Americas mRNA Vaccines for Animals Revenue Market Share by Country (2020-2025)
Figure 39. Americas mRNA Vaccines for Animals Sales Market Share by Type (2020-2025)
Figure 40. Americas mRNA Vaccines for Animals Sales Market Share by Application (2020-2025)
Figure 41. United States mRNA Vaccines for Animals Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada mRNA Vaccines for Animals Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico mRNA Vaccines for Animals Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil mRNA Vaccines for Animals Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC mRNA Vaccines for Animals Sales Market Share by Region in 2025
Figure 46. APAC mRNA Vaccines for Animals Revenue Market Share by Region (2020-2025)
Figure 47. APAC mRNA Vaccines for Animals Sales Market Share by Type (2020-2025)
Figure 48. APAC mRNA Vaccines for Animals Sales Market Share by Application (2020-2025)
Figure 49. China mRNA Vaccines for Animals Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan mRNA Vaccines for Animals Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea mRNA Vaccines for Animals Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia mRNA Vaccines for Animals Revenue Growth 2020-2025 ($ millions)
Figure 53. India mRNA Vaccines for Animals Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia mRNA Vaccines for Animals Revenue Growth 2020-2025 ($ millions)
Figure 55. China Taiwan mRNA Vaccines for Animals Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe mRNA Vaccines for Animals Sales Market Share by Country in 2025
Figure 57. Europe mRNA Vaccines for Animals Revenue Market Share by Country (2020-2025)
Figure 58. Europe mRNA Vaccines for Animals Sales Market Share by Type (2020-2025)
Figure 59. Europe mRNA Vaccines for Animals Sales Market Share by Application (2020-2025)
Figure 60. Germany mRNA Vaccines for Animals Revenue Growth 2020-2025 ($ millions)
Figure 61. France mRNA Vaccines for Animals Revenue Growth 2020-2025 ($ millions)
Figure 62. UK mRNA Vaccines for Animals Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy mRNA Vaccines for Animals Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia mRNA Vaccines for Animals Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa mRNA Vaccines for Animals Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa mRNA Vaccines for Animals Sales Market Share by Type (2020-2025)
Figure 67. Middle East & Africa mRNA Vaccines for Animals Sales Market Share by Application (2020-2025)
Figure 68. Egypt mRNA Vaccines for Animals Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa mRNA Vaccines for Animals Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel mRNA Vaccines for Animals Revenue Growth 2020-2025 ($ millions)
Figure 71. Turkey mRNA Vaccines for Animals Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries mRNA Vaccines for Animals Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of mRNA Vaccines for Animals in 2025
Figure 74. Manufacturing Process Analysis of mRNA Vaccines for Animals
Figure 75. Industry Chain Structure of mRNA Vaccines for Animals
Figure 76. Channels of Distribution
Figure 77. Global mRNA Vaccines for Animals Sales Market Forecast by Region (2026-2031)
Figure 78. Global mRNA Vaccines for Animals Revenue Market Share Forecast by Region (2026-2031)
Figure 79. Global mRNA Vaccines for Animals Sales Market Share Forecast by Type (2026-2031)
Figure 80. Global mRNA Vaccines for Animals Revenue Market Share Forecast by Type (2026-2031)
Figure 81. Global mRNA Vaccines for Animals Sales Market Share Forecast by Application (2026-2031)
Figure 82. Global mRNA Vaccines for Animals Revenue Market Share Forecast by Application (2026-2031)